Middletown, CT, United States of America

Sandra J Hofstead


Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 461(Granted Patents)


Location History:

  • Middletown, CT (US) (1991 - 1998)
  • Berlin, NH (US) (2007)

Company Filing History:


Years Active: 1991-2007

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Sandra J Hofstead

Introduction

Sandra J Hofstead is a prominent inventor based in Middletown, CT (US). She has made significant contributions to the field of biosynthesis and drug development, holding a total of six patents. Her work focuses on enhancing the production of valuable compounds through innovative methods.

Latest Patents

Among her latest patents, Hofstead has developed compositions and methods for altering the biosynthesis of taxanes and taxane-related compounds. This includes isolated nucleic acid and amino acid sequences for the phenylalanine aminomutase enzyme, along with methods for purifying this enzyme. Additionally, she has provided methods for altering the production of compounds in plant cell cultures, particularly targeting the production of taxanes and related compounds. Another notable patent involves thioether conjugates, which are drug/ligand compounds that hold potential for therapeutic applications.

Career Highlights

Hofstead has worked with notable companies such as Bristol-Myers Squibb Company and Bristol-Myers Company. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout her career, Hofstead has collaborated with esteemed colleagues, including David Willner and Pamela A Trail. These partnerships have fostered innovation and have been instrumental in advancing her research.

Conclusion

Sandra J Hofstead's contributions to the field of biosynthesis and drug development are noteworthy. Her innovative patents and collaborations highlight her commitment to advancing scientific knowledge and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…